Shah Capital, Novavax's second-largest shareholder, is pressing the biotech's board to pursue strategic changes, including a ...
Fintel reports that on November 10, 2025, B. Riley Securities reiterated coverage of Novavax (NasdaqGS:NVAX) with a Buy ...
Shah Capital increased its stake to about 8.3% and said the gap between Novavax’s scientific potential and its commercial ...
The 2025-2026 respiratory viral season is approaching.With it comes the familiar challenge of protecting our most vulnerable ...
Moderna Stock Is Climbing. It Has Been a Tumultuous Few Days for Pharma. Shares of Novavax, Pfizer, and other peers were also seeing gains on Tuesday. Both well-established and small, clinical-stage ...
Now, there’s a new player in town called CancerVax, and it’s getting a lot of attention. This article is going to look at ...